Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy. [electronic resource]
Producer: 20110809Description: 843-50 p. digitalISSN:- 1440-1746
- 2',5'-Oligoadenylate Synthetase -- genetics
- Adult
- Antiviral Agents -- therapeutic use
- Case-Control Studies
- Chi-Square Distribution
- DNA Mutational Analysis
- Drug Resistance, Viral
- Drug Therapy, Combination
- Egypt
- Exons
- Female
- Gene Frequency
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Liver Cirrhosis -- genetics
- Logistic Models
- Male
- Middle Aged
- Odds Ratio
- Phenotype
- Polyethylene Glycols -- therapeutic use
- Polymorphism, Restriction Fragment Length
- Polymorphism, Single Nucleotide
- RNA Splice Sites
- Recombinant Proteins
- Ribavirin -- therapeutic use
- Risk Assessment
- Risk Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.